Paid Clinical Trials and Focus Groups by Category |
|
|
|
-
7220 Woodland Drive
United States, Indiana 46278
United States
Earn $20 cash for participating in a new product evaluation. Participation in the trial should take approximately 45 minutes. Northwest Indianapolis.
-
United Kingdom, England
United Kingdom
Are you healthy? Want to join a clinical trial?
We’re looking for volunteers from all walks of life but particularly people from the black community and
Condition: Healthy
Interventions: Drug: MAP0004; Drug: IV Placebo; Drug: Placebo Inhaler; Drug: DHE 45
Sponsor: MAP Pharmaceuticals, Inc.
Not yet recruiting - verified March 2010
Condition: Healthy
Intervention: Drug: SRX246
Sponsor: Azevan Pharmaceuticals
Not yet recruiting - verified March 2010
Condition: Kidney Disease
Intervention:
Sponsor: University of California, San Francisco
Recruiting - verified February 2010
Conditions: HIV; Cardiovascular Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Kidney Stones
Intervention: Drug: Sodium thiosulfate
Sponsor: VA New York Harbor Healthcare System
Recruiting - verified March 2010
Conditions: Fluid Therapy; Water Electrolyte Imbalance; Acid Base Imbalance
Interventions: Drug: Crystalloid; Drug: Colloid
Sponsor: University of Nottingham
Not yet recruiting - verified March 2010
Conditions: Healthy; Diabetes Mellitus, Type 2
Interventions: Drug: NN9925 (oral); Drug: NN9925 (i.v.); Drug: placebo; Drug: NN9925 (oral); Drug: placebo
Sponsor: Novo Nordisk
Not yet recruiting - verified March 2010
Condition: Influenza A Virus, H5N1 Subtype
Interventions: Biological: VRC-AVIDNA036-00-VP; Biological: Monovalent Influenza Subunit Virion (Inactive H5N1) Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Eyelid Diseases
Intervention: Device: LT2420
Sponsor: Laboratoires Thea
Not yet recruiting - verified March 2010
Conditions: Distress; Breast Cancer
Intervention: Behavioral: couplinks website
Sponsors: British Columbia Cancer Agency; Canadian Breast Cancer Research Alliance
Not yet recruiting - verified March 2010
Condition: Low Back Pain
Intervention:
Sponsor: Texas Tech University Health Sciences Center
Recruiting - verified March 2010
Condition: Back Pain
Intervention:
Sponsor: Texas Tech University Health Sciences Center
Recruiting - verified March 2010
Condition: Healthy Volunteers
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified February 2010
Conditions: Focal Brain Lesion; Focal Lesions; fMRI
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
Condition: Clubfoot
Intervention: Other: Magnetic Resonance Imaging (MRI) of calf and foot
Sponsor: University of Aberdeen
Not yet recruiting - verified March 2010
Conditions: Cardiovascular Disease; Obstructive Sleep Apnea; Coronary Artery Disease
Interventions: Other: Healthy Lifestyles and Sleep Education plus PAP; Other: Healthy Lifestyles and Sleep Education plus Supplemental Oxygen; Other: Healthy Lifestyles and Sleep Education
Sponsors: University Hospitals of Cleveland; Case Western Reserve University; Partners HealthCare; Johns Hopkins University; VA Boston Healthcare System
Recruiting - verified March 2010
Condition: Antibiotic Associated Diarrhoea Including c.Difficile
Interventions: Dietary Supplement: probiotic actimel drink; Dietary Supplement: probiotic placebo drink
Sponsors: University of Sussex; Danone Institute International
Recruiting - verified March 2010
Condition: HIV
Interventions: Drug: Efavirenz; Drug: Over-encapsulated efavirenz
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified March 2010
Condition: Cognitive Impairment
Intervention: Other: Brain Fitness Program by Posit Science
Sponsors: San Francisco Veterans Administration Medical Center; Department of Defense
Not yet recruiting - verified March 2010
Conditions: Obesity; Injury
Interventions: Behavioral: Healthy Eating/Physical Activity; Behavioral: Safety/Injury Prevention
Sponsors: HealthPartners Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Washington; University of Minnesota School of Public Health
Not yet recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention: Drug: Rebif
Sponsor: EMD Serono
Not yet recruiting - verified March 2010
Condition: Intestinal Abnormalities
Intervention: Device: PillCam SB2
Sponsor: Given Imaging Ltd.
Recruiting - verified March 2010
Condition: Pharmacokinetics
Interventions: Drug: colchicine 0.6 mg; Drug: colchicine 0.6 mg; Drug: colchicine; Drug: colchicine; Drug: colchicine
Sponsor: Mutual Pharmaceutical Company, Inc.
Recruiting - verified March 2010
Condition: Biospecimen
Intervention:
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified January 2010
Conditions: Hairy Cell Leukemia (HCL); Chronic Lymphocytic Leukemia (CLL); Non-Hodgkins Lymphoma (NHL); Cutaneous T Cell Lymphoma (CTCL); Adult T Cell Lymphoma (ATL)
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified January 2010
Condition: Low Back Pain, Mechanical
Intervention: Other: Core Stabilization
Sponsors: Drexel University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Condition: Tobacco Use
Intervention: Other: Exposure to practice that has been trained in Pedialink CEASE
Sponsors: Massachusetts General Hospital; Flight Attendant Medical Research Institute
Recruiting - verified March 2010
Condition: Breast Cancer
Intervention: Dietary Supplement: Breast Health
Sponsor: Nutrasource Diagnostics Inc.
Recruiting - verified March 2010
Conditions: Cerebral Palsy; Children; Adolescents
Intervention: Behavioral: Physical Exercise
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified January 2010
Condition: Dry Eye
Intervention: Drug: Systane Ultra Lubricant Eye Drops
Sponsor: Alcon Research
Not yet recruiting - verified March 2010
Condition: Pain
Intervention: Other: Acupuncture
Sponsors: University of Washington; Bastyr University
Recruiting - verified March 2010
Condition: Dengue Virus
Interventions: Biological: Investigational Vaccine for DEN1; Other: Placebo injection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; Organization of Teratology Information Specialists (OTIS); Abbott
Recruiting - verified March 2010
Condition: Diabetic Peripheral Neuropathy
Interventions: Other: Skin biopsy; Other: Skin biopsy
Sponsors: Albany Medical College; Endo Pharmaceuticals
Recruiting - verified March 2010
Conditions: Metabolic Syndrome; Diabetes; Prediabetes; Hypertension
Intervention:
Sponsor: West Virginia School of Osteopathic Medicine
Recruiting - verified March 2010
Condition: Asthma
Intervention: Drug: 10 mg tablet of montelukast (Singulair)
Sponsors: Nemours Children's Clinic; Merck Investigator Initiated Studies Program
Recruiting - verified March 2010
Condition: Influenza
Intervention: Biological: Inactivated Influenza A/H5N1/Indonesia/05/05 (clade 2)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Conditions: Rotator Cuff Tear; Proximal Humerus Fractures; Malunions; Chronic Proximal Humerus Dislocations
Intervention:
Sponsor: Loma Linda University
Not yet recruiting - verified March 2010
Conditions: Congenital FXIII Deficiency; Healthy
Interventions: Drug: recombinant factor XIII; Drug: recombinant factor XIII
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Melanoma
Intervention:
Sponsor: University of Pittsburgh
Not yet recruiting - verified March 2010
Condition: Induced Abortion
Intervention: Procedure: D & C abortion
Sponsors: Planned Parenthood of New York City, Inc.; Society of Family Planning
Not yet recruiting - verified March 2010
Condition: Parkinson's Disease
Intervention: Behavioral: PC based training
Sponsors: Department of Veterans Affairs; University of California, Davis
Not yet recruiting - verified March 2010
Condition: Inguinal Hernia
Intervention: Behavioral: Mastery Learning TEP Curriculum
Sponsors: Mayo Clinic; National Center for Research Resources (NCRR)
Recruiting - verified March 2010
Condition: Retinal Vein Occlusions
Interventions: Drug: Avastin; Drug: Osurdex; Drug: Avastin
Sponsor: Maturi, Raj K., M.D., P.C.
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: multi-dose JNJ-39758979 /matching placebo; Drug: single dose NJ-39758979/ matching placebo
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Condition: Endothelial Function
Interventions: Dietary Supplement: Cinnamon; Dietary Supplement: Oregano; Dietary Supplement: Ginger; Dietary Supplement: Rosemary; Dietary Supplement: Black pepper; Dietary Supplement: Placebo
Sponsors: Laval University; McCormick Canada Co
Recruiting - verified March 2010
Condition: Stress
Intervention:
Sponsor: SPD Development Company Limited
Recruiting - verified March 2010
Conditions: Pregnancy; Weight Gain
Interventions: Behavioral: Lifestyle Intervention group; Behavioral: Standard of Care
Sponsor: Emory University
Not yet recruiting - verified March 2010
Condition: Pharmacokinetics
Interventions: Drug: Acetylsalicylic Acid (Aspirin BAY1019036); Drug: Alka Seltzer Extra Strength; Drug: Aspirin Migraine; Drug: Aspirin Aspro
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: CMX157; Drug: Placebo; Drug: Viread
Sponsor: Chimerix
Not yet recruiting - verified March 2010
Conditions: Pneumococcal Nasopharyngeal Colonization; Invasive Pneumococcal Disease
Intervention:
Sponsors: Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH); Centers for Disease Control and Prevention
Recruiting - verified March 2010
Condition: Obesity
Interventions: Behavioral: Busy Bodies/Better Bites; Behavioral: Healthy Spots/Safe Tots
Sponsors: HealthPartners Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified March 2010
Conditions: Bipolar Disorder; Cyclothymia; Borderline Personality Disorder
Intervention: Other: Mental health telemetry (MHT)
Sponsors: Sunnybrook Health Sciences Centre; Motorola Canada
Not yet recruiting - verified March 2010
Condition: Transient Tachypnea
Intervention: Other: Prophylactic CPAP Administration
Sponsor: New York Hospital Queens
Recruiting - verified February 2010
Condition: Healthy Volunteers
Interventions: Dietary Supplement: Single High Dose Cholecalciferol; Dietary Supplement: Daily Dose Cholecalciferol
Sponsor: Mayo Clinic
Recruiting - verified March 2010
Condition: Constipation-predominant Irritable Bowel Syndrome
Intervention: Drug: Lubiprostone
Sponsors: Cedars-Sinai Medical Center; Takeda Pharmaceuticals North America, Inc.
Not yet recruiting - verified December 2009
Condition: Postoperative Pain
Intervention: Drug: cyclobenzaprine
Sponsor: NorthShore University HealthSystem Research Institute
Not yet recruiting - verified March 2010
Condition: Obesity
Interventions: Behavioral: Social network building intervention; Behavioral: Home visit
Sponsors: Vanderbilt University; American Heart Association
Not yet recruiting - verified March 2010
Condition: Diabetic Vascular Complications
Intervention:
Sponsor: Winthrop University Hospital
Recruiting - verified March 2010
Condition: Female Sexual Dysfunction
Intervention:
Sponsors: East Suburban Ob Gyn; West Penn Allegheny Health System
Not yet recruiting - verified February 2010
Conditions: Degenerative Joint Disease; Osteoarthritis; Total Knee Arthroplasty
Interventions: Device: PEAK PlasmaBlade 4.0; Device: Traditional Electrosurgery with scalpel
Sponsor: Peak Surgical, Inc.
Recruiting - verified March 2010
Condition: Diabetes
Intervention:
Sponsor: Beth Israel Deaconess Medical Center
Recruiting - verified March 2010
Condition: Insulin Resistance
Intervention:
Sponsors: Children's Hospital Boston; University of Massachusetts
Recruiting - verified March 2010
Condition: Advanced Cancer
Intervention: Behavioral: Living with Hope Program
Sponsor: University of Saskatchewan
Recruiting - verified March 2010
Condition: Breast Cancer Mortality
Intervention: Other: Invitation for breast screening
Sponsors: University of Oxford; Department of Health, United Kingdom
Not yet recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491)
Sponsor: Takeda Global Research & Development Center, Inc.
Not yet recruiting - verified February 2010
Condition: Nutrition
Interventions: Other: test starter infant formula; Other: test starter infant formula with synbiotics; Other: control standard formula
Sponsor: Nestlé Nutrition Corporate
Not yet recruiting - verified March 2010
Condition: Female Sexual Dysfunction
Interventions: Drug: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%; Drug: Topical study cream; Drug: GRAS cream
Sponsor: East Suburban Ob Gyn
Not yet recruiting - verified March 2010
Condition: Individuals at Risk for Depression
Interventions: Behavioral: AIM Web based intervention + surveillance; Behavioral: AIM web based intervention; Behavioral: Educational website
Sponsor: Northwestern University
Recruiting - verified March 2010
Condition: Breast Cancer
Intervention:
Sponsors: University of Pittsburgh; National Center for Research Resources (NCRR)
Recruiting - verified March 2010
Condition: Distal Subungual Onychomycosis
Interventions: Drug: Terbinafine Hydrochloride; Other: Purified Water
Sponsor: Nitric BioTherapeutics, Inc
Not yet recruiting - verified March 2010
Conditions: Mild Cognitive Impairment; Alzheimer's Disease
Intervention:
Sponsors: Alzheimer's Disease Cooperative Study (ADCS); National Institute on Aging (NIA); National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Conditions: Cardiovascular Disease; Inflammation
Intervention: Dietary Supplement: Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)
Sponsors: Penn State University; United States Department of Agriculture
Not yet recruiting - verified February 2010
Condition: Sleep Deprivation
Intervention: Other: Sleep Enhancement Program (SEP)
Sponsors: University of Arizona; Arizona Biomedical Research Commission (ABRC)
Not yet recruiting - verified March 2010
Condition: Healthy
Interventions: Biological: REGN727; Biological: Placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi-Aventis
Not yet recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Intervention: Drug: AZD5069
Sponsors: AstraZeneca; Quintiles
Recruiting - verified March 2010
Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With T(15;17)(q22;q12); Adult Acute Myeloid Leukemia With T(16;16)(p13;q22); Adult Acute Myeloid Leukemia With T(8;21)(q22;q22); Atypical Chronic Myeloid Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Chronic Phase Chronic Myelogenous Leukemia; De Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Myelodysplastic/Myeloproliferative Disease, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma
Interventions: Drug: plerixafor; Biological: filgrastim; Procedure: peripheral blood stem cell transplantation; Procedure: allogeneic hematopoietic stem cell transplantation
Sponsor: Fred Hutchinson Cancer Research Center
Not yet recruiting - verified February 2010
Condition: Systemic Lupus Erythematosus
Intervention:
Sponsors: North Shore Long Island Jewish Health System; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Pregnancy
Intervention:
Sponsor: SPD Development Company Limited
Recruiting - verified February 2010
Condition: Cystic Fibrosis
Intervention:
Sponsors: CF Therapeutics Development Network Coordinating Center; Cystic Fibrosis Foundation
Recruiting - verified March 2010
Condition: Familial Hypercholesterolaemia
Interventions: Drug: rosuvastatin calcium; Drug: rosuvastatin calcium; Drug: rosuvastatin calcium
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Colorectal Neoplasms
Interventions: Behavioral: Stepped CRCS Interventions; Behavioral: Control
Sponsors: The University of Texas Health Science Center, Houston; Duke University; Boston University
Recruiting - verified March 2010
Condition: Screening of Colonic Polyps
Interventions: Other: Warm water; Other: Control
Sponsor: VA Greater Los Angeles Healthcare System
Recruiting - verified February 2010
Condition: Type II Diabetes Mellitus
Intervention: Other: Spice polyphenols
Sponsor: University of California, Los Angeles
Recruiting - verified February 2010
Condition: Hormone Withdrawal Associated Symptoms
Interventions: Drug: EE20/DRSP (YAZ, BAY86-5300); Drug: Ethinylestradiol (EE) and desogestrel (DSG) (Mercilon)
Sponsor: Bayer
Not yet recruiting - verified February 2010
Condition: Colorectal Cancer
Intervention:
Sponsors: Newcastle University; Northumbria Healthcare NHS Foundation Trust
Recruiting - verified February 2010
Condition: Lumbar Spinal Stenosis
Intervention: Procedure: Minimally Invasive Lumbar Decompression
Sponsors: The Center for Pain Relief, Inc.; Vertos Medical
Recruiting - verified March 2010
Condition: Pregnancy
Intervention: Procedure: Induction of Labor
Sponsor: Madigan Army Medical Center
Recruiting - verified February 2010
Condition: Glaucoma
Intervention:
Sponsors: North Shore Long Island Jewish Health System; Nassau University Medical Center
Recruiting - verified February 2010
Condition: Gait
Interventions: Behavioral: skill based exercise; Behavioral: aerobic conditioning
Sponsors: University of Pittsburgh; National Institute on Aging (NIA)
Not yet recruiting - verified February 2010
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine-Admixture 1; Biological: TetraVax-DV Vaccine-Admixture 2; Biological: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
Not yet recruiting - verified February 2010
Conditions: Bone Marrow; Bone Marrow Stromal Cells; Mesenchymal Stem Cells; Blood Donors
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified January 2010
Conditions: Pre-Hypertension; Hypertension
Interventions: Drug: Potassium, Magnesium, Citrate; Drug: Potassium Chloride
Sponsor: University of Texas Southwestern Medical Center
Recruiting - verified April 2009
Condition: Gastroparesis
Interventions: Drug: [2-13C] uracil; Drug: [2-13C] uracil, placebo
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Recruiting - verified February 2010
Conditions: Traumatic Brain Injury; Post-Traumatic Stress Disorder
Intervention:
Sponsors: St. Louis University; Department of Defense
Recruiting - verified February 2010
Condition: Ischaemia-reperfusion (IR) Injury
Interventions: Drug: C-type natriuretic peptide (CNP); Drug: Saline; Drug: Acetylcholine
Sponsors: Queen Mary University of London; University College, London
Not yet recruiting - verified February 2010
Conditions: Wounds and Injuries; Wound Healing; Ulcer
Intervention:
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified November 2009
Condition: Dengue Virus
Interventions: Biological: Investigational Vaccine for Dengue Virus Subtype 2; Other: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Dietary Intervention
Interventions: Dietary Supplement: probiotic; Dietary Supplement: prebiotic; Dietary Supplement: Synbiotic; Dietary Supplement: Placebo
Sponsor: University of Reading
Not yet recruiting - verified February 2010
Condition: Vasomotor Symptoms
Intervention: Behavioral: Yoga
Sponsors: Wake Forest University; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified October 2009
Condition: Breast Cancer
Intervention:
Sponsor: Park Nicollet Institute
Recruiting - verified February 2010
Condition: Acne
Intervention: Drug: apremilast
Sponsors: The University of North Carolina, Chapel Hill; Celgene Corporation
Recruiting - verified February 2010
Condition: Pregnancy
Intervention: Drug: duloxetine
Sponsors: Eli Lilly and Company; Kendle International
Recruiting - verified February 2010
Conditions: HIV; HIV Infections
Intervention: Drug: darunavir/ritonavir then atazanavir/ritonavir
Sponsor: St Stephens Aids Trust
Not yet recruiting - verified February 2010
Condition: Dyslipidemia
Interventions: Drug: Niaspan; Drug: Comparator: Placebo
Sponsor: Merck
Recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: granisetron IV; Drug: granisetron patch
Sponsor: Prostrakan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Pregnancy Outcome Trends in Low-resource Geographic Areas
Intervention: Other: There is no intervention associated with this study.
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified December 2009
Condition: CVD
Intervention: Behavioral: Dietician electonic support
Sponsors: Group Health Cooperative; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified February 2010
Conditions: Cannabis Use; Drug Abuse
Intervention: Drug: Cannabis Cigarette
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified December 2009
Condition: Hepatitis C
Interventions: Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: Ad6NSmut; AdCh3NSmut; Biological: AdCh3NSmut; Ad6NSmut; Biological: AdCh3NSmut; Ad6NSmut
Sponsors: Okairos; University of Oxford
Recruiting - verified February 2010
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Placebo; Drug: Tiotropium
Sponsors: Boehringer Ingelheim Pharmaceuticals; Pfizer
Recruiting - verified March 2010
Conditions: Sedentary Lifestyle; Risk of Disability; Aging
Intervention: Behavioral: Lifestyle modification
Sponsors: University of Florida; National Institute on Aging (NIA); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2010
Condition: Asthma
Intervention:
Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Methamphetamine Addiction
Interventions: Other: Placebo; Drug: Rivastigmine
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Conditions: Acute Lung Injury; Adult Respiratory Distress Syndrome
Intervention:
Sponsor: Boston Medical Center
Not yet recruiting - verified February 2010
Condition: Colon, Irritable
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Inflammation; Colon, Irritable; Colonic Diseases, Functional; Irritable Bowel Syndrome
Intervention:
Sponsors: The University of North Carolina, Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: PTSD; TBI (Traumatic Brain Injury)
Intervention:
Sponsors: Department of Veterans Affairs; University of California, Berkeley
Not yet recruiting - verified February 2010
Condition: Nephropathy
Interventions: Drug: placebo; Drug: atorvastatin
Sponsor: University of Oklahoma
Not yet recruiting - verified February 2010
Condition: Speech Perception
Intervention: Device: Nucleus 5 Cochlear implant
Sponsor: Cochlear
Not yet recruiting - verified February 2010
Condition: PTSD
Intervention: Other: Supported Education
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified February 2010
Condition: Cardiovascular Diseases
Interventions: Other: Walnuts; Other: Walnuts; Other: Walnuts; Other: Walnuts
Sponsors: University of California, Davis; California Walnut Commission
Not yet recruiting - verified February 2010
Condition: Gingivitis
Interventions: Drug: Marketed toothpaste; Drug: Experimental toothpaste
Sponsor: GlaxoSmithKline
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
Not yet recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin; Drug: Metformin
Sponsors: Bristol-Myers Squibb; AstraZeneca
Not yet recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Saxagliptin; Drug: Saxagliptin; Drug: Metformin; Drug: Metformin
Sponsors: Bristol-Myers Squibb; AstraZeneca
Not yet recruiting - verified February 2010
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
Sponsors: GlaxoSmithKline; Shionogi
Recruiting - verified March 2010
Condition: Pain
Interventions: Drug: Morphine; Drug: Morphine; Drug: Morphine
Sponsor: University of British Columbia
Not yet recruiting - verified February 2010
Condition: Methamphetamine Dependence
Intervention: Behavioral: Intensive Motivational Interviewing
Sponsor: Public Health Institute, California
Recruiting - verified February 2010
Condition: Becker Muscular Dystrophy
Interventions: Drug: Tadalafil; Drug: Placebo
Sponsors: Cedars-Sinai Medical Center; Muscular Dystrophy Association
Recruiting - verified March 2010
Condition: Pruritus
Interventions: Drug: Naloxone; Drug: Saline/Morphine
Sponsor: University of British Columbia
Not yet recruiting - verified February 2010
Conditions: Chronic Fatigue Syndrome; Cognitive Impairments
Interventions: Drug: Lisdexamfetamine Dimesylate; Drug: Placebo Comparator: Sugar pill
Sponsors: Rochester Center for Behavioral Medicine; Shire Pharmaceutical Development
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Metformin (Diabex); Drug: Metformin (Glucophage™); Drug: Metformin (Diabex); Drug: Metformin (Glucophage™)
Sponsors: Bristol-Myers Squibb; AstraZeneca
Not yet recruiting - verified February 2010
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Eltrombopag; Drug: Eltrombopag
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Dapagliflozin; Drug: Rifampin
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified February 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: Placebo; Drug: SCH 527123; Drug: SCH 527123; Drug: SCH 527123; Drug: Placebo
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Histamine Induced Itch
Interventions: Drug: A:JNJ-39758979/Placebo #1; Drug: B: JNJ-39758979 Matching Placebo /Placebo #2; Drug: C:Cetirizine/JNJ-39758979 Matching Placebo
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Condition: Chronic Lymphocytic Leukemia
Intervention: Other: No Intervention
Sponsor: Dartmouth-Hitchcock Medical Center
Not yet recruiting - verified February 2010
Condition: Osteoporosis
Interventions: Drug: Odanacatib; Drug: Comparator: Placebo
Sponsor: Merck
Recruiting - verified March 2010
Condition: Colorectal Cancer
Interventions: Drug: Eicosapentaenoic acid free fatty acid; Drug: Placebo
Sponsor: University of Leeds
Not yet recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: AZD9742; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Hepatitis C Virus
Interventions: Drug: Ortho Tri-Cyclen®; Drug: BMS-650032
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified February 2010
Conditions: Chronic Granulomatous Disease (CGD); Atherosclerosis; Immune Deficiencies; Inflammatory Bowel Disease
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: Schizophrenia
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified January 2010
Condition: Brittle Nail Syndrome
Interventions: Drug: topical cyclosporine ophthalmic suspension 0.05%; Drug: vehicle
Sponsors: The University of North Carolina, Chapel Hill; Allergan
Recruiting - verified February 2010
Conditions: Nephrogenic Fibrosing Dermopathy; Nephrogenic Systemic Fibrosis
Intervention: Procedure: Plasmapheresis
Sponsor: Loma Linda University
Recruiting - verified March 2010
Condition: Methamphetamine Addiction
Interventions: Drug: Perindopril; Other: Placebo
Sponsors: Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Condition: Nicotine Addiction
Interventions: Drug: Cycloserine; Drug: Placebo
Sponsors: Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Condition: Methamphetamine Addiction
Interventions: Drug: Placebo (Solution without NAC); Drug: N-acetylcysteine; Drug: N-Acetylcysteine
Sponsors: Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified March 2010
Condition: Anxiety Disorders
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified December 2009
Condition: Alzheimer Disease
Interventions: Drug: BMS-708163; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified January 2010
Condition: Influenza
Interventions: Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A; Biological: GSK Biologicals' FluLaval®; Biological: Placebo (saline); Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Cervical Intraepithelial Neoplasia; Human Papillomavirus
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2009
Condition: Levels of Fatty Acids in the Blood Cells of Infants
Intervention:
Sponsors: Mead Johnson; University of Alberta
Recruiting - verified March 2010
Condition: Sarcopenia
Interventions: Dietary Supplement: Juven; Dietary Supplement: Juven
Sponsors: University of Alabama at Birmingham; National Center for Complementary and Alternative Medicine (NCCAM)
Recruiting - verified February 2010
Condition: Post-Traumatic Headache
Interventions: Drug: sumatriptan/naproxen sodium; Drug: Placebo
Sponsors: Cady, Roger, M.D.; GlaxoSmithKline
Not yet recruiting - verified March 2010
Conditions: Major Depressive Disorder; Healthy Volunteers
Intervention: Drug: Duloxetine
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: AZD5069; Drug: Placebo
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Accelerated Intimal Hyperplasia
Interventions: Drug: BMS-813160; Drug: BMS-813160; Drug: BMS-813160; Drug: BMS-813160; Drug: BMS-813160; Drug: BMS-813160; Drug: [14C] BMS-813160; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Recruiting - verified January 2010
Condition: Otitis Media
Intervention: Device: Acclarent Iontophoresis System
Sponsor: Acclarent
Recruiting - verified January 2010
Condition: Obesity
Interventions: Behavioral: Technology Supported; Behavioral: Gold Standard
Sponsors: Northwestern University; Illinois Institute of Technology
Not yet recruiting - verified March 2010
Condition: Osteoarthritis
Intervention:
Sponsor: Biomet, Inc.
Not yet recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: PF-03382792 Cohort 1; Drug: PF-03382792 Cohort 2; Drug: PF-03382792; Drug: Food Effect cohort; Drug: CSF cohort
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: HIV; HIV Infections
Interventions: Behavioral: 1-sided messages; Behavioral: 2-sided messages
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)
Recruiting - verified February 2010
Conditions: Pulmonary Hypertension; Sickle Cell Disease; Thalassemia
Interventions: Drug: L-Glutamine; Drug: L-Glutamine
Sponsor: Children's Hospital & Research Center Oakland
Recruiting - verified February 2010
Condition: HIV Infections
Intervention: Drug: TMC278LA
Sponsor: St Stephens Aids Trust
Recruiting - verified March 2010
Conditions: Cervical Cancers; Vulvar Cancers; Vaginal Cancers; Genital Warts; Human Papillomavirus (HPV) Infection
Interventions: Biological: V503; Biological: Comparator: Placebo to V503
Sponsor: Merck
Recruiting - verified March 2010
Conditions: Healthy; Obesity
Interventions: Drug: '2-0453; Drug: '2-0453; Drug: placebo
Sponsor: Novo Nordisk
Recruiting - verified February 2010
Conditions: Glutathione; Healthy
Interventions: Drug: Glutathione supplementation; Drug: Glutathione supplementation; Other: Placebo
Sponsor: Penn State University
Recruiting - verified January 2010
Conditions: Insomnia; Hepatic Insufficiency
Intervention: Drug: MK4305
Sponsor: Merck
Recruiting - verified March 2010
Conditions: Posttraumatic Growth; Posttraumatic Stress Disorder
Intervention:
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified February 2010
Conditions: Sarcoma; Hepatic Insufficiency
Intervention: Drug: ridaforolimus
Sponsors: Merck; Ariad Pharmaceuticals
Recruiting - verified March 2010
Condition: Hepatitis C Virus
Intervention: Drug: TMC435
Sponsor: Tibotec Pharmaceuticals, Ireland
Recruiting - verified February 2010
Condition: Obesity
Interventions: Behavioral: More-Intensive; Behavioral: Less-Intensive
Sponsors: University of Pittsburgh; Milton S. Hershey Medical Center; Department of Defense
Not yet recruiting - verified March 2010
Condition: Colorectal Neoplasms
Intervention: Device: Third Eye Retroscope
Sponsor: Avantis Medical Systems
Recruiting - verified February 2010
Condition: 2009 H1N1 Influenza Virus
Intervention: Biological: 2009 H1N1 Virus Vaccine
Sponsors: University of Rochester; National Institutes of Health (NIH)
Not yet recruiting - verified March 2010
Conditions: Pregnancy; Unexplained Infertility
Interventions: Drug: Letrozole (aromatase inhibitor); Drug: Clomiphene Citrate; Drug: Follicle Stimulating Hormone (gonadotropin)
Sponsors: Yale University; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Penn State University; University of Colorado, Denver; University of Michigan; University of Pennsylvania; University of Texas; University of Vermont; Wayne State University
Not yet recruiting - verified March 2010
Condition: Cardiovascular Disease
Interventions: Other: Apple Juice/Grape Juice; Other: Grape Juice/Apple Juice
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified March 2010
Condition: Healthy Volunteers
Interventions: Drug: losmapimod 1 mg; Drug: losmapimod; Drug: losmapimod 15 mg
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Conditions: Healthy; Diabetes Mellitus, Type 2
Interventions: Drug: NN9924 (oral); Drug: placebo; Drug: NN9924 (oral); Drug: placebo; Drug: NN9924 (s.c.); Drug: NN9924 (i.v.)
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Conditions: Aging; Alzheimer's Disease
Interventions: Other: Exercise Training; Other: Cognitive Training; Other: Flexibility Training; Other: Educational Sessions
Sponsors: The Cleveland Clinic; National Institutes of Health (NIH)
Recruiting - verified February 2009
Condition: Cocaine Dependence
Intervention:
Sponsors: National Institute on Drug Abuse (NIDA); National Institute on Drug Abuse and University of Maryland, College Park, MD
Recruiting - verified December 2009
Condition: HIV Infections
Interventions: Drug: Emtricitabine (FTC); Drug: Tenofovir disoproxil fumarate (TDF); Drug: Efavirenz (EFV)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified December 2009
Condition: Alzheimer Disease
Interventions: Drug: Donepezil; Drug: BMS-708163
Sponsor: Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Alzheimer Disease
Interventions: Drug: galantamine; Drug: galantamine; Drug: BMS-708163
Sponsor: Bristol-Myers Squibb
Recruiting - verified February 2010
Condition: Schizophrenia
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2009
Conditions: Cannabis; Dependence; Cannabis Abuse; Pharmacokinetics; fMRI
Interventions: Drug: Sativex(Registered Trademark); Drug: THC
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2009
Conditions: Substance Abuse; Disorders
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Conditions: Nicotine Dependence; Drug Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified January 2009
Conditions: Nicotine Dependence; Drug Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2009
Condition: Healthy
Intervention: Drug: HM10760A or placebo
Sponsor: Hanmi Pharmaceutical Company Limited
Recruiting - verified February 2010
Condition: Movement Disorder
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified October 2009
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 formulation 3; Drug: GSK2248761 formulation 1; Drug: GSK2248761 reference formulation; Drug: GSK2248761 formulation 2 or 4
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Nicotine Dependence
Intervention: Device: Transcranial Magnetic Stimulation
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Condition: Skin Cancer
Interventions: Dietary Supplement: Omega-3 PUFA; Dietary Supplement: Gelatine
Sponsor: University of Manchester
Recruiting - verified March 2010
Condition: Drug Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified June 2009
Conditions: Cocaine Dependence; Cannabis Dependence; Schizophrenia
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified July 2009
Conditions: Tick-Borne Encephalitis; Encephalitis, Tick-Borne; Tick-Borne Disease; Glycoprotein E, Flavivirus; NSI Protein, Flavivirus
Intervention: Biological: FSME-IMMUN 0.5ml Baxter
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2009
Condition: Substance Use Disorders
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified April 2009
Condition: Nicotine Dependence
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified May 2009
Condition: Human Papillomavirus
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2010
Condition: Cocaine Dependence
Interventions: Other: Placebo; Drug: Rivastigmine
Sponsors: Baylor College of Medicine; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Condition: Diabetes
Interventions: Drug: MBX-2982; Drug: MBX-2982; Drug: MBX-2982; Drug: Sitagliptin; Drug: placebo
Sponsor: Metabolex
Recruiting - verified March 2010
Condition: Closed Fractures
Intervention:
Sponsor: University of Tennessee
Recruiting - verified February 2010
Condition: Deep Venous Thrombosis
Intervention: Drug: Low-Molecular-Weight Heparin
Sponsor: University of Tennessee
Recruiting - verified February 2010
Condition: Respiratory Tract Infections
Interventions: Drug: PF-04287881; Drug: Placebo; Drug: PF-04287881; Drug: Placebo; Drug: PF-04287881; Drug: Placebo; Drug: PF-04287881; Drug: Placebo; Drug: PF-04287881; Drug: Placebo; Drug: PF-04287881; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Cannabis Use
Intervention: Device: Repetitive Transcranial Magnetic Stimulation
Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2010
Condition: Arthritis, Rheumatoid
Intervention: Drug: CP 690,550 oral solutions
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: Hepatic Insufficiency
Intervention: Drug: BMS-650032
Sponsor: Bristol-Myers Squibb
Recruiting - verified December 2009
Condition: Healthy
Interventions: Biological: REGN727; Biological: Placebo
Sponsors: Regeneron Pharmaceuticals; Sanofi-Aventis
Recruiting - verified February 2010
Condition: Healthy
Intervention: Procedure: Blood draw
Sponsor: Wyeth
Recruiting - verified March 2010
Conditions: Drug Abuse; Prenatal Drug Exposure
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified September 2009
Conditions: QTc Evaluation; Electrocardiography
Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039); Drug: Placebo
Sponsor: Bayer
Recruiting - verified March 2010
Condition: Healthy
Intervention: Biological: REGN668
Sponsors: Regeneron Pharmaceuticals; Sanofi-Aventis
Recruiting - verified February 2010
Condition: Healthy Volunteers
Interventions: Drug: PF-04427429; Drug: PF-04427429; Drug: PF-04427429
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Schizophrenia
Intervention:
Sponsor: National Eye Institute (NEI)
Recruiting - verified October 2009
Conditions: Herpesvirus; Adenovirus; Cytomegalovirus; Human Papillomavirus; Human Polyomavirus; Influenza Virus; Rhinovirus; Coronavirus; Respiratory Syncytial Virus
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Condition: Myelodysplastic Syndromes
Interventions: Drug: decitabine; Drug: azacitidine
Sponsor: Eisai Inc.
Not yet recruiting - verified February 2010
Condition: Erectile Dysfunction
Intervention: Other: delivery system
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365; Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Veramyst /Artificial tears; Drug: Veramyst / Artificial tears lubricant eye drops; Drug: Veramyst nasal spray and Olopatadine eye drops; Other: Veramyst placebo and Olopatadine0.2% eye drops
Sponsors: University of Chicago; GlaxoSmithKline
Recruiting - verified November 2009
Condition: Acute Myocardial Infarction
Intervention:
Sponsor: Scripps Translational Science Institute
Recruiting - verified March 2010
Condition: Type 2 Diabetes Mellitus (T2DM)
Interventions: Drug: Dapagliflozin; Drug: Metformin XR; Drug: Glucophage
Sponsors: Bristol-Myers Squibb; AstraZeneca
Recruiting - verified January 2010
Conditions: Haemophilus Influenzae Type B Related Disease; Pneumonia; Meningitis; Cellulitis; Osteomyelitis; Epiglottis
Interventions: Biological: InfanrixTM; Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108); Biological: ActHIBTM; Biological: PentacelTM; Biological: PediarixTM; Biological: PrevnarTM; Biological: RotarixTM; Biological: EngerixTM-B
Sponsor: GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Plasmodium Falciparum
Intervention: Biological: Plasmodium falciparum Sporozoite (strain NF-54; Anopheles stephensi mosquitoes) Vaccine, Live, Inactivated (gamma irradiation)
Sponsors: Sanaria Inc.; The PATH Malaria Vaccine Initiative (MVI)
Recruiting - verified March 2010
Condition: Healthy
Intervention: Drug: ABT-384
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Influenza, Human
Intervention: Biological: VRC-FLUDNA056-00VP
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Condition: Hepatitis C
Interventions: Drug: Midazolam; Drug: BMS-791325
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified November 2009
Condition: Contraception
Interventions: Drug: LNG20; Drug: Mirena
Sponsor: Medicines360
Recruiting - verified February 2010
Condition: Tuberculosis
Interventions: Drug: PNU-100480; Drug: Placebo; Drug: PNU-100480; Drug: Placebo; Drug: PNU-100480; Drug: Placebo; Drug: PNU-100480; Drug: Placebo; Drug: PNU-100480; Drug: Placebo; Drug: PNU-100480; Drug: Placebo; Drug: Linezolid
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Influenza
Intervention: Biological: Inactivated H1N1 Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Condition: HIV Infections
Intervention: Behavioral: Modified client adherence profiling and intervention tailoring (CAP-IT)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Condition: Alzheimer's Disease
Intervention: Drug: [18F]AZD4694
Sponsors: AstraZeneca; Banner Alzheimer's Institute
Recruiting - verified February 2010
Condition: Infant Immunizations
Intervention: Biological: Pediacel® and Infanrix™-IPV/Hib
Sponsors: Dalhousie University; IWK Health Centre; Sanofi Pasteur MSD
Recruiting - verified October 2009
Condition: Hypersensitivity
Interventions: Drug: Sugammadex 4 mg/kg; Drug: Sugammadex 16 mg/kg; Drug: Placebo
Sponsor: Schering-Plough
Recruiting - verified March 2010
Condition: Hemiplegia
Intervention: Device: EMS 2000
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Condition: Human Papillomavirus Infection
Interventions: Biological: V503; Biological: Comparator: Menactra™ (Concomitant); Biological: Comparator: Adacel™ (concomitant); Biological: Comparator: Menactra™ (Non-Concomitant); Biological: Comparator: Adacel™ (Non-concomitant)
Sponsor: Merck
Recruiting - verified March 2010
Conditions: Healthy; Memory Impairment
Interventions: Drug: AZD8529; Drug: Placebo to match AZD8529
Sponsor: AstraZeneca
Recruiting - verified February 2010
Condition: Asthma
Interventions: Drug: ABT-308; Drug: ABT-308; Drug: Placebo; Drug: Placebo
Sponsor: Abbott
Recruiting - verified January 2010
Condition: Chronic Hepatitis C
Interventions: Drug: BMS-790052; Drug: Ortho Tri-Cyclen®
Sponsor: Bristol-Myers Squibb
Recruiting - verified November 2009
Condition: Metastatic Prostate Cancer
Intervention:
Sponsor: Fred Hutchinson Cancer Research Center
Recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: AZD2423; Drug: Placebo; Drug: AZD2423; Drug: AZD2423; Drug: AZD2423
Sponsor: AstraZeneca
Recruiting - verified March 2010
Conditions: Alzheimer's Disease; Hypertension
Interventions: Drug: Ramipril; Drug: Placebo
Sponsor: University of Wisconsin, Madison
Recruiting - verified March 2010
Condition: Osteoarthritis, Knee
Interventions: Drug: PF-04457845; Drug: PF-04457845; Drug: Naproxen; Drug: Naproxen
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Intervention: Other: Simulated Diabetes Training
Sponsors: HealthPartners Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified March 2010
Condition: Staphylococcus Enterotoxin B
Intervention: Biological: STEBVax
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified February 2010
Condition: Assessment, Geriatric
Intervention:
Sponsors: City of Hope Medical Center; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Bronchodilator Agents; Drug: Normal saline; Device: Dead space breathing; Device: Room air breathing
Sponsors: Queen's University; Canadian Lung Association
Not yet recruiting - verified March 2010
Condition: Healthy Volunteers
Interventions: Drug: AMG 157; Drug: AMG 157 Placebo
Sponsor: Amgen
Recruiting - verified February 2010
Condition: Transient Hypothyroxinemia
Intervention:
Sponsor: Christiana Care Health Services
Recruiting - verified March 2010
Condition: Sarcopenia
Interventions: Dietary Supplement: Leucine; Dietary Supplement: Leucine
Sponsors: The University of Texas, Galveston; National Space Biomedical Research Institute
Recruiting - verified March 2010
Condition: Parents Who Have Lost a Child to Cancer
Intervention: Behavioral: Questionnaires/Interviews
Sponsors: Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI); Dana Farber Cancer Institute/Harvard Medical School; Ohio State University; University of Memphis
Recruiting - verified March 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nonmalignant Neoplasm
Interventions: Biological: trivalent influenza vaccine; Other: immunoenzyme technique; Other: laboratory biomarker analysis
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified August 2009
Condition: Paroxysmal Atrial Fibrillation
Interventions: Procedure: Atrial Fibrillation ablation procedure; Device: NAVISTAR THERMOCOOL and NAVISTAR EZ STEER THERMOCOOL
Sponsor: Biosense Webster, Inc.
Recruiting - verified February 2010
Conditions: Obesity; Overweight; Healthy
Interventions: Drug: PF-04620110; Drug: Placebo
Sponsors: Pfizer; Bristol-Myers Squibb
Recruiting - verified March 2010
Condition: Vertebral Compression Fractures
Intervention: Device: OsseoFix Spinal Fracture Reduction System
Sponsor: Alphatec Spine, Inc.
Recruiting - verified March 2010
Condition: Healthy
Interventions: Other: Osteopathic Manipulation; Other: Placebo
Sponsors: West Virginia School of Osteopathic Medicine; American Osteopathic Association
Recruiting - verified March 2010
Condition: Gulf War Syndrome
Interventions: Procedure: Lactulose Breath Test; Drug: Rifaximin; Drug: Placebo; Drug: Erythromycin ethylsuccinate (EES); Drug: Placebo; Drug: Bismuth subsalicylate
Sponsor: VA Merit Review, DOD (Department of Defense)
Recruiting - verified February 2010
Condition: Chronic Hepatitis C
Intervention: Drug: Pegylated Interferons (Peg-IFN) and Ribavirin
Sponsors: University of Manitoba; Roche Pharma AG
Recruiting - verified February 2010
Conditions: Inflammation; Obesity; Pregnancy; Fetal Growth
Intervention: Dietary Supplement: Omega-3 Fish Oil
Sponsors: MetroHealth Medical Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Condition: HPV Infections
Interventions: Biological: Cervarix; Biological: Gardasil
Sponsor: Health Protection Agency
Recruiting - verified August 2009
Conditions: Functional Dyspepsia; Small Intestinal Bacterial Overgrowth; Chronic Abdominal Discomfort
Interventions: Drug: Rifaximin; Procedure: Lactulose Breath Test; Drug: Placebo
Sponsor: National Institutes of Health (NIH)
Recruiting - verified February 2010
Condition: Muscle Loss
Interventions: Biological: ACE-031; Biological: Placebo
Sponsor: Acceleron Pharma, Inc.
Recruiting - verified February 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nonmalignant Neoplasm; Viral Infection
Interventions: Other: cytology specimen collection procedure; Other: fluorescent antibody technique; Procedure: assessment of therapy complications
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified August 2009
Condition: Healthy Volunteers
Intervention: Drug: Immediate Release Niacin, Extended Release Niacin, Endotoxin
Sponsor: University of Pennsylvania
Recruiting - verified March 2010
Condition: Squamous Cell Carcinoma of Oropharynx
Interventions: Radiation: IMRT; Drug: Cisplatin; Drug: Carboplatin
Sponsor: Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified March 2010
Condition: Hepatitis C Virus
Interventions: Drug: BMS-791325; Drug: BMS-791325; Drug: BMS-791325; Drug: BMS-791325; Drug: BMS-791325; Drug: BMS-791325; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified November 2009
Conditions: Mouth Cancer; Oral Cancer
Interventions: Drug: Pioglitazone; Drug: Placebo
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: Osteoporosis; Osteopenia; Fragility Fractures
Interventions: Behavioral: FRAX + Decision Aid; Behavioral: FRAX estimated fracture risk
Sponsors: Mayo Clinic; Foundation for Informed Medical Decision Making; Olmsted Medical Center
Recruiting - verified February 2010
Condition: Type 2 Diabetes Mellitus
Intervention: Other: There are no interventions, this is not a treatment study.
Sponsor: Washington University School of Medicine
Not yet recruiting - verified February 2010
Conditions: Amenorrhea; Female Athlete Triad Syndrome
Interventions: Drug: Transdermal 17Beta-estradiol, progesterone; Drug: Ethinyl Estradiol + Desogestrel; Dietary Supplement: Elemental Calcium and Vitamin D
Sponsors: Massachusetts General Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: ACU-4429; Drug: matching placebo tablet
Sponsors: Acucela Inc.; Otsuka Pharmaceutical Co., Ltd.
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: Clopidogrel; Drug: Clopidogrel and Lansoprazole; Drug: Clopidogrel and Dexlansoprazole; Drug: Clopidogrel and Omeprazole; Drug: Clopidogrel and Esomeprazole
Sponsor: Takeda Global Research & Development Center, Inc.
Recruiting - verified March 2010
Conditions: Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Genital Lesions; PAP Test Abnormalities; HPV Infections
Intervention: Biological: V503
Sponsor: Merck
Recruiting - verified March 2010
Conditions: Smoking Cessation; Habits; Smoking
Interventions: Behavioral: Survey; Behavioral: Counseling; Behavioral: Survey; Behavioral: Counseling
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: HIV; Asthma
Interventions: Drug: Darunavir; Drug: Ritonavir; Drug: Beclomethasone Dipropionate HFA
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified July 2009
Condition: Preeclampsia
Intervention:
Sponsors: Universitaire de Sherbrooke; Fondation des étoiles
Recruiting - verified February 2010
Conditions: Myopia; Hyperopia; Corneal Infiltrative Events
Intervention: Device: lotrafilcon A contact lenses
Sponsors: University Hospital Case Medical Center; Alcon Laboratories
Recruiting - verified January 2010
Conditions: Attention Deficit Hyperactivity Disorder; Nicotine Dependence; Cannabis Use Disorder
Intervention: Drug: Bupropion, Cognitive Behavioral Therapy
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Condition: Type 2 Diabetes
Interventions: Behavioral: Dietary; Behavioral: Physical Activity; Behavioral: Self-Regulatory Approaches
Sponsors: University of Tennessee; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Abbott Diabetes Care
Recruiting - verified March 2010
Conditions: Epilepsy; Epilepsy, Temporal Lobe; Depression; Depressive Disorder, Major
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Contraception
Interventions: Drug: Mirena (Levonorgestrel IUS, BAY86-5028); Drug: Implanon, (Etonogestrel)
Sponsor: Bayer
Recruiting - verified March 2010
Conditions: Down Syndrome; Amyloid Beta-Protein
Intervention: Drug: BAY94-9172
Sponsor: Bayer
Recruiting - verified February 2010
Conditions: Breast Cancer; Healthy Volunteer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Psoriasis
Intervention: Drug: CNTO 1959; Placebo
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Conditions: Pulmonary Hypertension; Pulmonary Arterial Hypertension; Interstitial Lung Disease
Interventions: Other: Blood Gas; Other: Pulmonary Exercise Test; Other: Spirometry; Other: Breath Condensate Collector
Sponsor: North Shore Long Island Jewish Health System
Recruiting - verified March 2010
Condition: Healthy
Intervention: Drug: STP206 or vehicle control
Sponsor: Sigma Tau Pharmaceuticals, Inc.
Recruiting - verified March 2010
Conditions: Nicotine Dependence; Smoking Cessation
Interventions: Other: Varenicline and smoking cessation counseling; Behavioral: Exercise or relaxation treatment
Sponsors: University of Connecticut Health Center; National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA)
Recruiting - verified February 2010
Condition: Autism
Intervention:
Sponsor: State University of New York - Upstate Medical University
Not yet recruiting - verified February 2010
Condition: Variola Major (Smallpox)
Interventions: Biological: IMVAMUNE® (liquid, intradermal); Biological: IMVAMUNE® (lyophilized); Biological: IMVAMUNE® (liquid, subcutaneous)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Conditions: Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes
Interventions: Drug: Fludarabine Phosphate; Drug: Tacrolimus; Drug: Thiotepa; Radiation: Total-Body Irradiation (TBI); Device: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
Sponsors: Yale University; National Cancer Institute (NCI); Fred Hutchinson Cancer Research Center
Recruiting - verified March 2010
Condition: Influenza
Interventions: Biological: A/Anhui/05; Biological: MF-59; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified December 2009
Condition: Stroke
Interventions: Device: rTMS; Procedure: Motor learning training; Procedure: rTMS and Tracking; Device: Sham rTMS
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified March 2010
Condition: Haemophilus Influenzae (NTHI)
Intervention: Biological: NTHi Strain 2019
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2009
Conditions: Anosognosia; Alzheimer's Disease; Mild Cognitive Impairment
Intervention:
Sponsor: University of Wisconsin, Madison
Recruiting - verified March 2010
Condition: Obesity
Interventions: Drug: BMS-830216; Drug: BMS-830216; Drug: BMS-830216; Drug: BMS-830216; Drug: BMS-830216; Drug: BMS-830216; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Recruiting - verified January 2010
Conditions: Movement Disorders; Heathly Subjects
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Cancer
Interventions: Other: immunological diagnostic method; Other: physiologic testing
Sponsors: Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified June 2009
Conditions: Liver Fibrosis; Hepatitis C Virus
Intervention: Procedure: Comparator: Magnetic Resonance Elastography (MRE)
Sponsor: Merck
Recruiting - verified March 2010
Conditions: Lymphohistiocytosis, Hemophagocytic; Common Variable Immunodeficiency; Severe Combined Immunodeficiency
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Adolescent Mania
Interventions: Drug: Quetiapine & Placebo; Drug: Lithium and Placebo; Other: Healthy Controls
Sponsors: University of Cincinnati; Children's Hospital Medical Center, Cincinnati
Recruiting - verified March 2010
Conditions: Depression; Mood Disorders; Depressive Disorder
Intervention: Drug: Citalopram
Sponsor: Stanford University
Recruiting - verified February 2010
Condition: Mental Disorders
Intervention: Procedure: Testing (MRS, US, DEXA)
Sponsor: Washington University School of Medicine
Recruiting - verified March 2010
Conditions: Becker Muscular Dystrophy; Limb-Girdle Muscular Dystrophy, Type 2A; Calpain-3 Deficiency; Limb-Girdle Muscular Dystrophy, Type 2B; Miyoshi Myopathy; Dysferlin Deficiency; Limb-Girdle Muscular Dystrophy, Type 2I; FKRP-deficiency
Intervention:
Sponsors: Cooperative International Neuromuscular Research Group; Children's Research Institute; Muscular Dystrophy Association; Levine Children's Hospital at Carolinas Medical Center
Recruiting - verified March 2010
Condition: Malaria
Intervention: Drug: BSAM2/Alhydrogel + CPG 7909
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2009
Conditions: Healthy Volunteer; Fatigue; Depression
Intervention:
Sponsor: National Institute of Nursing Research (NINR)
Recruiting - verified February 2010
Conditions: Pancreatic Fistula; Distal Pancreatectomy Complications; Falciform Patch Pancreatic Closure; Fibrin Glue Pancreatic Closure
Interventions: Procedure: Falciform patch and fibrin glue application; Procedure: standard pancreatic closure
Sponsor: Thomas Jefferson University
Recruiting - verified February 2010
Condition: Smoking Cessation
Interventions: Behavioral: Quitline Service + 10 automated monitoring calls; Behavioral: Quitline service + 20 automated monitoring calls
Sponsors: Indiana University; Free and Clear, Inc.; Kaiser Foundation Hospitals, Center for Health Research; University of Washington
Not yet recruiting - verified March 2010
Condition: Rett Syndrome
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified April 2009
Condition: Tobacco Use Disorder
Intervention: Drug: Nicotrol Inhaler
Sponsors: Hartford Hospital; University of Connecticut Health Center
Recruiting - verified February 2010
Condition: Phenylketonuria
Interventions: Dietary Supplement: high oleic sunflower oil; Dietary Supplement: microalgal oil; Dietary Supplement: microalgal oil; Dietary Supplement: microalgal oil; Dietary Supplement: microalgal oil
Sponsors: Ludwig-Maximilians - University of Munich; European Union
Recruiting - verified January 2010
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: CNTO 3649; Placebo
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Condition: Allergic Airway Disease
Intervention: Drug: Broccoli sprout extract
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Irritable Bowel Syndrome
Intervention: Drug: Desipramine
Sponsor: Washington University School of Medicine
Recruiting - verified March 2010
Conditions: Ovarian Cancer; Endometrial Cancer
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010
Condition: Renal Impairment
Intervention: Drug: IK-1001
Sponsor: Ikaria Holdings Inc.
Recruiting - verified February 2010
Condition: Pregnancy
Interventions: Procedure: IUC; Procedure: IUC; Device: Levonorgestrel-releasing Intrauterine System [LNG-IUC] or FlexiT380 Copper Intrauterine Device [CuT380-IUD]; Device: Levonorgestrel-releasing Intrauterine System [LNG-IUC] or FlexiT380 Copper Intrauterine Device [CuT380-IUD]
Sponsors: University of British Columbia; Women's Health Research Institute of British Columbia; College Of Family Physicians
Recruiting - verified February 2010
Condition: Healthy
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2010
Conditions: Uterine Fibroids; Uterine Myomas
Intervention: Device: Halt System
Sponsor: Halt Medical, Inc
Recruiting - verified March 2010
Condition: Heart Failure
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Condition: Spinal Cord Injury
Intervention:
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Conditions: Pregnancy; Pregnant Women
Intervention:
Sponsors: University of Washington; Stanford University
Recruiting - verified March 2010
Conditions: Cocaine Addiction; Cocaine Abuse
Intervention:
Sponsor: National Institute on Drug Abuse (NIDA)
Not yet recruiting - verified January 2010
Condition: Diabetes Mellitus Type II Non Insulin Dependent
Interventions: Dietary Supplement: Vitamin E; Dietary Supplement: Vitamin C; Dietary Supplement: Lipid Oxidation
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: HIV Infections; Peripheral Neuropathy
Interventions: Drug: Duloxetine; Drug: Duloxetine placebo; Drug: Methadone; Drug: Methadone placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Congestive Heart Failure
Interventions: Other: Ultrafiltration; Other: Ultrafiltration using BVM
Sponsors: Christiana Care Health Services; Daxor Corporation
Recruiting - verified March 2010
Condition: Neurological Conditions
Intervention: Other: tissue and data repository
Sponsors: The University of Texas Health Science Center, Houston; The Vivian L. Smith Center for Neurologic Research
Recruiting - verified March 2010
Condition: Hypertension
Interventions: Drug: Aliskiren; Drug: Aliskiren; Drug: Comparator: Losartan; Drug: Comparator: Placebo to Aliskiren; Drug: Comparator: Placebo to Losartan
Sponsor: Merck
Recruiting - verified March 2010
Conditions: Osteoarthritis; Traumatic Arthritis; Avascular Necrosis of the Femoral Condyle; Moderate Varus; Valgus; Flexion Deformities
Intervention: Device: NexGen LPS-Flex Mobile Bearing Knee
Sponsor: Zimmer, Inc.
Recruiting - verified March 2010
Conditions: Obesity; Diabetes
Intervention: Behavioral: lifestyle intervention
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Condition: Mild Traumatic Brain Injury
Intervention:
Sponsor: Department of Veterans Affairs
Not yet recruiting - verified February 2010
Condition: Infertility
Intervention: Procedure: oocyte freezing
Sponsors: North Shore Long Island Jewish Health System; EMD Serono
Recruiting - verified March 2010
Conditions: HIV; HIV Infections
Intervention: Behavioral: Video
Sponsors: North Bronx Healthcare Network; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Condition: Cutaneous T-Cell Lymphoma
Intervention: Procedure: skin biopsy
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified March 2010
Condition: Diagnostic or Therapeutic Laparoscopy
Intervention:
Sponsor: University of Arkansas
Recruiting - verified March 2010
Conditions: Polymyalgia Rheumatica; Rheumatoid Arthritis; Rheumatic Disease
Intervention:
Sponsor: Lahey Clinic
Recruiting - verified March 2010
Conditions: Obesity; Insulin Resistance
Interventions: Drug: placebo; Drug: pioglitazone
Sponsor: Oregon Health and Science University
Recruiting - verified March 2010
Conditions: Aphasia; Stroke
Intervention:
Sponsors: University of Cincinnati; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified March 2010
Conditions: Chronic Sinusitis; Chronic Rhinosinusitis; Nasal Polyps
Intervention: Drug: Prednisone
Sponsor: Northwestern University
Recruiting - verified February 2010
Condition: Intraocular Pressure
Intervention:
Sponsor: The University of Texas Health Science Center, Houston
Not yet recruiting - verified February 2010
Condition: Smoking Cessation
Interventions: Drug: varenicline; Drug: placebo
Sponsors: Roswell Park Cancer Institute; Pfizer
Recruiting - verified March 2010
Condition: Human Papillomavirus Infection
Interventions: Behavioral: Compliance; Behavioral: Message sidedness
Sponsors: Indiana University; Merck
Not yet recruiting - verified February 2010
Condition: Intestinal Microbiome
Intervention: Drug: Ciprofloxacin hydrochloride
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2009
Condition: Health Status Unknown
Interventions: Other: biologic sample preservation procedure; Other: medical chart review; Other: survey administration; Procedure: evaluation of cancer risk factors
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified January 2009
Conditions: Breast Cancer; Chronic Myeloproliferative Disorders; Gestational Trophoblastic Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Neuroblastoma; Ovarian Cancer; Testicular Germ Cell Tumor
Interventions: Other: educational intervention; Other: laboratory biomarker analysis; Other: questionnaire administration; Other: survey administration; Procedure: psychosocial assessment and care; Procedure: stress management therapy; Procedure: support group therapy
Sponsors: University of Colorado, Denver; National Cancer Institute (NCI)
Recruiting - verified January 2009
Condition: Chronic Lung Disease
Intervention: Procedure: Infant Pulmonary Function Tests
Sponsors: University of Tennessee; University of Tennessee Health Science Center
Recruiting - verified March 2010
Conditions: Leiomyoma; Incontinence; Prolapse
Intervention:
Sponsor: University of Texas Southwestern Medical Center
Recruiting - verified January 2010
Condition: Pneumococcal Conjugate Vaccine
Intervention: Biological: 13vPnC
Sponsor: Wyeth
Recruiting - verified February 2010
Condition: Liver Failure
Interventions: Behavioral: Focus Groups; Behavioral: Personal Interviews
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified February 2010
Condition: Nocturia
Interventions: Behavioral: Behavioral; Drug: tamsulosin (alpha-adrenergic antagonist medication); Drug: placebo; Behavioral: placebo
Sponsors: Atlanta VA Medical Center; Emory University; University of Alabama at Birmingham
Recruiting - verified March 2010
Condition: Cancer
Interventions: Behavioral: Questionnaire; Other: Body Measurements; Behavioral: Self-help Materials
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified February 2010
Condition: HIV Infections
Interventions: Biological: Vaccine; Biological: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2009
Condition: Cigarette Smoking
Intervention: Behavioral: Smoking Cessation Guideline Implementation
Sponsors: Department of Veterans Affairs; National Jewish Hospital Quitline; Iowa State University
Recruiting - verified March 2010
Conditions: Thyroid Disease; Healthy
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2009
Condition: Postoperative Pain
Interventions: Drug: Oxycodone IR; Drug: Tapentadol IR
Sponsors: Ortho-McNeil Janssen Scientific Affairs, LLC; Grünenthal GmbH
Recruiting - verified February 2010
Condition: Physical Activity
Interventions: Behavioral: physical activity; Behavioral: physical activity information
Sponsor: University of Hawaii
Recruiting - verified March 2010
Condition: Human Papillomavirus (HPV) Type 16/18 Infections and Cervical Neoplasia.
Intervention: Biological: GSK580299, GSK Biological's HPV vaccine
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Postoperative Pain
Intervention: Other: Psychophysical testing, questionnaires, and genetics
Sponsor: University of Washington
Recruiting - verified March 2010
Condition: Smoking Cessation
Interventions: Behavioral: Decide2Quit; Behavioral: Smoking Coach
Sponsors: University of Alabama at Birmingham; Johns Hopkins University
Not yet recruiting - verified February 2010
Condition: Healthy Subjects
Interventions: Drug: 20% lipid infusion; Drug: glycerol
Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting - verified February 2010
Condition: Tularemia
Intervention: Biological: Live Francisella Tularensis Vaccine
Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting - verified February 2010
Condition: Osteoporosis
Intervention:
Sponsor: Emory University
Recruiting - verified February 2010
Condition: Alzheimer's Disease
Interventions: Drug: AZD3480; Drug: AZD3480
Sponsor: AstraZeneca
Recruiting - verified March 2010
Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Drug: Rapamycin
Sponsors: State University of New York - Upstate Medical University; Wyeth
Recruiting - verified February 2010
Conditions: Leukemia; Lymphoma; Myelodysplastic Syndromes
Interventions: Drug: busulfan; Drug: cyclophosphamide; Drug: fludarabine phosphate; Drug: mycophenolate mofetil; Drug: tacrolimus; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation
Sponsor: Northside Hospital, Inc.
Recruiting - verified March 2010
Condition: Diabetes
Interventions: Other: Calorie Restriction; Other: Exercise; Other: Calorie Restriction plus Exercise
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Systemic Lupus Erythematosus
Interventions: Other: Sugar Pill; Drug: N-acetylcysteine; Drug: N-acetylcysteine; Drug: N-acetylcysteine; Drug: N-acetylcysteine
Sponsor: State University of New York - Upstate Medical University
Recruiting - verified February 2010
Condition: Chronic Migraine
Interventions: Drug: propranolol LA; Drug: topiramate; Drug: placebo
Sponsors: The EMMES Corporation; National Institute of Neurological Disorders and Stroke (NINDS); Ortho-McNeil Janssen Scientific Affairs, LLC; CRC Operations Center
Recruiting - verified March 2010
Condition: Healthy
Interventions: Biological: MEDI-559; Other: Placebo; Biological: MEDI-559
Sponsor: MedImmune LLC
Recruiting - verified March 2010
Condition: Hip Replacement, Total
Intervention: Drug: Ceftobiprole
Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC
Recruiting - verified February 2010
Conditions: Distress; Hematopoietic Stem Cell Transplantation
Intervention: Behavioral: Problem Solving Education
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified August 2009
Condition: Infections
Intervention:
Sponsor: Southwest Regional Wound Care Center
Recruiting - verified March 2010
Condition: Epilepsy
Interventions: Behavioral: COPE (Creating Opportunities for Parent Empowerment); Behavioral: Standard education
Sponsors: Children's Hospital Boston; National Institute of Nursing Research (NINR)
Recruiting - verified March 2010
Conditions: Acute Decompensated Heart Failure; Heart Failure
Intervention:
Sponsors: University of Connecticut Health Center; CT Department of Public Health
Recruiting - verified February 2010
Conditions: Myocardial Infarction; Ischemia; Congestive Heart Failure
Intervention:
Sponsor: University of Connecticut Health Center
Recruiting - verified February 2010
Conditions: Ischemia; Coronary Disease
Intervention:
Sponsors: University of Connecticut Health Center; U.S. Army Research, Department of Defense
Recruiting - verified February 2010
Condition: Wound
Intervention:
Sponsor: Southwest Regional Wound Care Center
Recruiting - verified March 2010
Conditions: Diabetic Foot; Leg Ulcer; Decubitus Ulcer
Intervention:
Sponsor: Southwest Regional Wound Care Center
Recruiting - verified March 2010
Condition: Overactive Bladder
Intervention: Drug: Solifenicin (Vesicare)
Sponsor: New York University School of Medicine
Recruiting - verified March 2010
Condition: Pneumonia
Intervention: Drug: CP-70,429 and PF-03709270
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Gastroenteritis
Interventions: Drug: Lacidophil (experimental high dose); Drug: Lacidophil (experimental standard dose); Drug: Placebo
Sponsor: The Hospital for Sick Children
Recruiting - verified February 2010
Conditions: Alzheimer Disease; Amyloid Beta-Protein
Intervention: Drug: BAY94-9172 (ZK 6013443)
Sponsor: Bayer
Recruiting - verified March 2010
Conditions: Inflammation; Insulin Sensitivity
Interventions: Other: Weight Loss; Other: Aerobic Exercise Training
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2010
Condition: Obesity
Interventions: Behavioral: Individual telephone intervention; Behavioral: Group telephone intervention
Sponsors: State University of New York - Upstate Medical University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Colonoscopy
Intervention: Other: Colonoscopy
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2010
Condition: Plasmodium Falciparum Malaria
Intervention: Other: NF54 P. falciparum isolate
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2010
Condition: Papillomavirus Infections
Intervention:
Sponsors: University of Washington; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: Nilotinib Hydrochloride; Dietary Supplement: calcium carbonate
Sponsors: University of Pittsburgh; Novartis Pharmaceuticals
Recruiting - verified February 2010
Condition: Healthy
Interventions: Drug: Imatinib mesylate; Dietary Supplement: calcium carbonate
Sponsors: University of Pittsburgh; Novartis Pharmaceuticals
Recruiting - verified February 2010
Condition: Type II Diabetes Mellitus
Intervention: Other: Rosiglitazone with diet and exercise
Sponsors: American Scitech International; Proactive Clinical Research; GlaxoSmithKline
Not yet recruiting - verified March 2010
Conditions: Sleep Apnea; Age
Intervention: Other: hyperventilation and episodic hypoxia
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Condition: Metabolism
Intervention: Procedure: Blood draw
Sponsor: St. Jude Children's Research Hospital
Recruiting - verified February 2010
Condition: Diabetes Mellitus
Interventions: Drug: Comparison of the effect of aldosterone versus vehicle infusion; Drug: Comparison of the effect of aldosterone versus vehicle infusion
Sponsors: Vanderbilt University; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Brain Injuries
Interventions: Drug: CDP-Choline; Drug: Placebo
Sponsors: University of Pittsburgh; National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Condition: Subjects With Metabolic Syndrome Are at High Risk for Diabetes
Intervention: Behavioral: strength training
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not yet recruiting - verified March 2010
Condition: Atopic Dermatitis
Intervention: Biological: YFV-17D
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Communication Disorders; Developmental Disabilities
Intervention: Behavioral: Milieu Communication Teaching
Sponsors: University of Kansas; National Institute on Deafness and Other Communication Disorders (NIDCD)
Recruiting - verified March 2010
Condition: Hypercholesterolemia
Interventions: Drug: Vitamin D2; Drug: Vitamin D3; Drug: Placebo
Sponsors: Jewish Home, San Francisco; National Institute on Aging (NIA)
Recruiting - verified December 2009
Conditions: Osteoarthritis; Avascular Necrosis; Rheumatoid Arthritis
Intervention: Device: Cormet Hip Resurfacing
Sponsor: Corin
Recruiting - verified February 2010
Condition: Alcoholic Intoxication
Interventions: Drug: Alcohol; Procedure: Self-Administration
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified May 2009
Conditions: Early Pancreatic Neoplasia; Familial Pancreatic Neoplasia
Intervention:
Sponsors: Sidney Kimmel Comprehensive Cancer Center; V Foundation for Cancer Research
Recruiting - verified March 2010
Conditions: Diphtheria; Pertussis; Tetanus
Interventions: Drug: Placebo; Biological: Tdap
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified March 2010
Condition: Obesity
Interventions: Drug: Sincalide; Drug: Ursodiol Acid; Procedure: High Fat/Low Fat Diet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Painful Diabetic Neuropathy
Intervention: Procedure: Nerve Decompression
Sponsor: University of Texas Southwestern Medical Center
Recruiting - verified February 2010
Condition: Alcohol Drinking
Interventions: Drug: Varenicline; Drug: Varenicline (Chantix)
Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified January 2010
Condition: Retinoblastoma
Interventions: Genetic: DNA ploidy analysis; Genetic: DNA stability analysis; Genetic: Southern blotting; Genetic: genetic linkage analysis; Genetic: loss of heterozygosity analysis; Genetic: mutation analysis; Genetic: polymorphism analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: evaluation of cancer risk factors; Procedure: mutation carrier screening
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Obesity and Type 2 Diabetes
Interventions: Behavioral: Circuit Training; Behavioral: Circuit training + motivational interviewing; Behavioral: Control
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Obesity
Interventions: Dietary Supplement: Low fat diet; Dietary Supplement: High fat diet; Dietary Supplement: MCT diet
Sponsor: Oregon Health and Science University
Recruiting - verified February 2009
Conditions: Lumbar Spinal Stenosis; Neurogenic Intermittent Claudication
Interventions: Device: Superion™ Interspinous Spacer; Device: X-STOP® IPD® Device
Sponsor: VertiFlex, Incorporated
Recruiting - verified February 2010
Conditions: Postural Tachycardia Syndrome; Orthostatic Intolerance
Interventions: Drug: Carbidopa; Drug: Placebo
Sponsor: Vanderbilt University
Recruiting - verified March 2010
Condition: Shift Work Sleep Disorder
Intervention:
Sponsors: Henry Ford Health System; Cephalon
Recruiting - verified March 2010
Condition: Insomnia
Intervention:
Sponsors: Henry Ford Health System; Takeda Pharmaceuticals North America, Inc.
Recruiting - verified March 2010
Condition: Smoking
Interventions: Behavioral: Focus Group; Behavioral: Questionnaire
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Conditions: End-stage Heart Failure; End-stage Pulmonary Failure; End Stage Liver Failure; Morbid Obesity; Recalcitrant Epilepsy Requiring Surgery; Healthy Subjects
Interventions: Dietary Supplement: To surgery patients, Tocotrienol or Tocopherol capsules.; Dietary Supplement: Tocotrienol or Tocopherol to healthy subjects.
Sponsor: Ohio State University
Recruiting - verified March 2010
Condition: Shoulder Pain
Intervention: Procedure: Exercises
Sponsor: University of Texas Southwestern Medical Center
Recruiting - verified April 2008
Condition: Hypertension, Pulmonary
Interventions: Procedure: Excerise Training; Procedure: Patient Education (Placebo)
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified April 2009
Condition: Psoriasis
Interventions: Procedure: Narrow band (310-312 nm) ultraviolet light B phototherapy; Drug: etanercept
Sponsor: University of California, San Francisco
Recruiting - verified February 2010
Conditions: Prostatitis; Cystitis, Interstitial; Urinary Bladder, Overactive; Chronic Pelvic Pain Syndrome; Painful Bladder Syndrome
Intervention:
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Children's Hospital Boston
Recruiting - verified March 2010
Conditions: Cardiovascular Diseases; Mood Disorders; Inflammation
Interventions: Dietary Supplement: Fish Oil; Dietary Supplement: Soybean Oil (Placebo)
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Center for Complementary and Alternative Medicine (NCCAM); Office of Dietary Supplements (ODS)
Recruiting - verified March 2010
Condition: Hypovitaminosis D
Interventions: Drug: vitamin D3; Drug: vitamin D3
Sponsors: Creighton University; University of Nebraska
Recruiting - verified March 2010
Condition: Escherichia Coli Infections
Interventions: Drug: Ciprofloxacin 500 mg; Biological: Peru-15-pCTB; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Beta Thalassemia Major; Congenital Anemias
Intervention: Genetic: GCSF, Central venous line placement, Stem cell Collection (leukapheresis)
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified March 2010
Condition: Urinary Tract Infection
Intervention:
Sponsors: University of Washington; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Conditions: Chest Pain; Coronary Occlusion; Coronary Artery Disease
Intervention:
Sponsor: William Beaumont Hospitals
Recruiting - verified March 2010
Conditions: Overweight; Eating Behavior; Binge Eating
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2009
Condition: Anemia
Intervention:
Sponsors: Stanford University; National Institute on Aging (NIA)
Recruiting - verified February 2010
Condition: Colorectal Cancer
Intervention: Behavioral: Questionnaire
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention: Drug: INFNb-1b
Sponsor: The University of North Carolina, Chapel Hill
Recruiting - verified February 2010
Condition: Asthma
Intervention:
Sponsors: University of Kansas; Kansas University Endowment Association
Recruiting - verified March 2010
Conditions: Neurofibromatosis Type 1; Reading Disabilities
Interventions: Behavioral: Tutoring Program I; Behavioral: Tutoring Program II
Sponsors: Vanderbilt University; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: HIV Infections
Intervention: Biological: Ad26.ENVA.01 HIV-1 vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2008
Condition: Healthy
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Meningococcal Infections; Pneumococcal Infections
Interventions: Biological: NeisVacC (Meningococcal C conjugate vaccine); Biological: Menjugate (Meningococcal C conjugate vaccine)
Sponsors: Health Protection Agency; Institute of Child Health; National Institute of Biological Standards and Control
Recruiting - verified January 2010
Condition: Substance-related Discorder
Interventions: Drug: Nicotine; Drug: Carfentanil
Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting - verified October 2009
Conditions: Immunosuppression; Kidney Transplantation; Graft Rejection
Intervention: Procedure: Infusion of Donor Hematopoietic Stem Cells and Campath-1H
Sponsors: Northwestern University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Wounds and Injuries
Intervention:
Sponsors: Ohio State University; National Healing Corporation
Recruiting - verified March 2010
Conditions: Colonoscopy; Adenomatous Polyp; Neoplastic
Intervention: Other: Narrow Band Imaging
Sponsors: Kansas City Veteran Affairs Medical Center; Midwest Biomedical Research Foundation
Recruiting - verified February 2009
Condition: Sexual Dysfunction
Interventions: Behavioral: Focus Group; Behavioral: TENDRILS; Behavioral: Questionnaires; Behavioral: Sexual Counseling Sessions
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Epilepsy
Intervention:
Sponsors: Beth Israel Deaconess Medical Center; Newton-Wellesley Hospital; Brigham and Women's Hospital
Recruiting - verified March 2010
Conditions: Pulmonary Disease, Chronic Obstructive; Emphysema; Bronchitis, Chronic
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2009
Condition: Dental Anxiety
Interventions: Behavioral: Computer Assisted Relaxation Learning; Behavioral: Pamphlet
Sponsors: University of Washington; National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified March 2010
Condition: Infrarenal Abdominal Aortic Aneurysm
Intervention: Device: Anaconda Stent Graft System
Sponsors: Terumo CVS; Vascutek Ltd., Scotland
Recruiting - verified March 2010
Conditions: Depression, Postpartum; Depression
Interventions: Behavioral: The Postpartum Prevention Program (PPP); Behavioral: Enhanced care as usual (ECU)
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified March 2009
Conditions: Preterm Delivery; Short Cervix; Short Uterine Cervical Length
Interventions: Drug: progesterone; Drug: placebo
Sponsors: Columbia Laboratories; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2010
Conditions: Intrathoracic Malignancies; Unilateral Vocal Cord Paralysis
Interventions: Other: voice evaluation and fMRI; Other: undergo voice evaluation and fMRI prior
Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting - verified March 2010
Condition: Alcohol Abuse
Interventions: Behavioral: Motivational Enhancement Therapy (MET)/CBT+CM; Behavioral: Motivational Enhancement Therapy (MET)/CBT
Sponsors: University of Arkansas; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: Marijuana Abuse and Dependence
Interventions: Behavioral: Psychotherapy; Behavioral: Computerized Psychotherapy; Behavioral: Motivational enhancement therapy
Sponsor: University of Arkansas
Recruiting - verified March 2010
Conditions: Severe Burns; Major Trauma
Intervention:
Sponsor: United States Army Institute of Surgical Research
Recruiting - verified February 2010
Condition: Healthy
Interventions: Biological: MEDI-557; Biological: MEDI-557; Biological: MEDI-557; Biological: MEDI-557
Sponsor: MedImmune LLC
Recruiting - verified February 2010
Condition: Eastern Equine Encephalitis
Intervention: Biological: Inactivated, Dried, TSI-GSD 104, EEE
Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting - verified March 2010
Condition: Venezuelan Equine Encephalomyelitis
Intervention: Biological: VEE TC-83
Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting - verified March 2010
Condition: Venezuelan Equine Encephalomyelitis
Intervention: Biological: VEE C-84
Sponsor: U.S. Army Medical Research and Materiel Command
Recruiting - verified March 2010
Conditions: Barrett's Esophagus; Esophageal Neoplasms
Intervention:
Sponsors: Kansas City Veteran Affairs Medical Center; TAP Pharmaceutical Products Inc.
Recruiting - verified February 2010
Condition: Marijuana Abuse
Interventions: Behavioral: Motivational Enhancement Therapy (MET)/CBT+CM; Behavioral: Motivational Enhancement Therapy (MET)/CBT+CM; Behavioral: Motivational Enhancement Therapy (MET)/CBT
Sponsors: University of Arkansas; National Institutes of Health (NIH)
Recruiting - verified March 2010
Conditions: Metabolic Syndrome; Insulin Resistance
Interventions: Drug: omega-3 fatty acid; Drug: placebo
Sponsors: University of Kentucky; GlaxoSmithKline; National Institutes of Health (NIH)
Recruiting - verified March 2010
Conditions: CNS Cancer; CNS BRAIN
Intervention: Drug: temozolomide followed by high dose busulfan and thiotepa
Sponsors: Memorial Sloan-Kettering Cancer Center; University of Calgary; Northwestern University; Northwestern Memorial Hospital; University of Wisconsin, Madison; Massachusetts General Hospital
Recruiting - verified March 2010
Conditions: Barrett Esophagus; Gastroesophageal Reflux
Intervention:
Sponsor: Kansas City Veteran Affairs Medical Center
Recruiting - verified February 2010
Conditions: Coronary Angiography; Coronary Artery Bypass Grafting; Coronary Artery Disease
Intervention:
Sponsor: William Beaumont Hospitals
Recruiting - verified February 2010
Conditions: Growth; Development
Interventions: Other: assisted exercise; Other: cuddle
Sponsor: University of California, Irvine
Recruiting - verified March 2010
Conditions: Barrett's Esophagus; Gastroesophageal Reflux Disease; Esophageal Adenocarcinoma
Intervention:
Sponsor: Midwest Biomedical Research Foundation
Recruiting - verified February 2009
Condition: Preeclampsia
Intervention:
Sponsors: University of Kansas; Diagnostic Technologies Ltd.
Recruiting - verified March 2010
Condition: Variola Major (Smallpox)
Interventions: Biological: MVA-BN; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified October 2009
Conditions: Adipocyte Differentiation; Insulin Resistance
Intervention: Other: Administration of 70% deuterated water
Sponsors: University of Vermont; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Conditions: Keratoconjunctivitis Sicca; Xeropthalmia
Interventions: Procedure: Acupuncture; Procedure: Sham acupuncture
Sponsors: Walter Reed Army Medical Center; Malcolm Grow USAF Medical Center
Recruiting - verified March 2010
Conditions: Central Auditory Processing Disorder; Traumatic Brain Injury; Hearing Loss
Intervention: Procedure: Audiological testing
Sponsors: Department of Veterans Affairs; Walter Reed Army Medical Center
Recruiting - verified February 2010
Condition: Atopic Dermatitis
Intervention:
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Atopic Dermatitis and Vaccinia Network
Recruiting - verified February 2010
Condition: Coronary Disease
Intervention:
Sponsor: William Beaumont Hospitals
Recruiting - verified February 2010
Condition: Coronavirus (SARS-CoV)
Interventions: Drug: Aluminum hydroxide; Biological: SARS-CoV; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting - verified March 2010
Conditions: PTSD; Sleep Disorders
Interventions: Drug: prazosin; Other: placebo
Sponsor: Department of Veterans Affairs
Recruiting - verified January 2010
Condition: Malignant Glioma
Intervention: Biological: REOLYSIN®
Sponsor: Oncolytics Biotech
Recruiting - verified March 2010
Condition: Obesity
Interventions: Other: Glucose tolerance test; Other: glucose tolerance test solution; Other: Diet Coke; Other: Coke Zero
Sponsor: Christiana Care Health Services
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Behavioral: Computer Program; Behavioral: Focus Group; Other: Written Materials
Sponsors: M.D. Anderson Cancer Center; National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: Atopic Dermatitis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Corneal Neovascularization
Intervention: Drug: Bevacizumab (Avastin)
Sponsors: Walter Reed Army Medical Center; Massachusetts Eye and Ear Infirmary
Recruiting - verified March 2010
Condition: Healthy
Intervention: Other: Evaluating Educational Models
Sponsor: Christiana Care Health Services
Recruiting - verified March 2010
Condition: Substance-Related Disorders
Interventions: Drug: midazolam(drug), digoxin (drug); Drug: Bupropion (drug); Drug: Methadone (drug)
Sponsor: University of Washington
Recruiting - verified March 2010
Conditions: Schizophrenia; Cardiovascular Disease
Intervention:
Sponsors: Washington University School of Medicine; National Alliance for Research on Schizophrenia and Depression
Recruiting - verified March 2010
Condition: Respiratory Illness
Interventions: Behavioral: Secondhand Smoke Reduction, Smoking Cessation; Behavioral: Asthma Education with Secondhand Smoke Reduction
Sponsors: University of Rochester; Halcyon Hill Foundation
Recruiting - verified December 2007
Condition: Endometrial Cancer
Intervention: Behavioral: Questionnaire
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Conditions: Chuvash Polycythemia; Cerebrovascular Disease; Pulmonary Hypertension; Sickle Cell Anemia
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Condition: Sickle Cell Disease
Interventions: Biological: filgrastim; Drug: cyclophosphamide; Drug: fludarabine phosphate; Drug: mycophenolate mofetil; Drug: tacrolimus; Procedure: allogeneic bone marrow transplantation; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation; Radiation: total-body irradiation
Sponsors: Sidney Kimmel Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Epidemiology
Intervention: Behavioral: Supplemental Survey
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Soft Tissue Injuries
Intervention: Device: Extracorporeal shock wave therapy
Sponsor: Tissue Regeneration Technologies
Recruiting - verified March 2010
Condition: Type 2 Diabetes
Intervention: Behavioral: Practice Facilitation
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified March 2010
Condition: Health
Interventions: Behavioral: Focus Groups; Behavioral: Questionnaire; Behavioral: Interview
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Conditions: Traumatic Brain Injury; Veterans
Intervention:
Sponsors: University of Wisconsin, Madison; Department of Veterans Affairs
Recruiting - verified March 2010
Condition: Pediatric Cancers
Intervention: Behavioral: Questionnaires
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Acculturation
Intervention: Behavioral: Questionnaire
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Conditions: Overweight; Obesity
Interventions: Behavioral: Fructose; Behavioral: glucose; Behavioral: non-caloric sweetener
Sponsors: University of Washington; Seattle Children's Hospital
Recruiting - verified March 2010
Conditions: Metabolic Syndrome X; Prediabetic State
Interventions: Drug: Fenofibrate; Drug: Pioglitazone and Fenofibrate; Drug: Fenofibrate; Drug: Pioglitazone and Fenofibrate
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Condition: Intimate Partner Violence
Interventions: Behavioral: Public Health Nurse Home Visit; Behavioral: Intimate Partner Violence (IPV) Protocol
Sponsors: Johns Hopkins University; National Institute of Nursing Research (NINR)
Recruiting - verified February 2010
Conditions: Male Hypogonadism; Muscle Atrophy; Prostate Enlargement; Sarcopenia
Interventions: Drug: Testosterone Enanthate; Behavioral: Collection of 3-day food logs with counseling of subjects; Drug: Finasteride; Behavioral: Collection of 3-day food logs with counseling of subjects; Drug: Testosterone Enanthate; Drug: Finasteride; Behavioral: Collection of 3-day food logs with counseling of subjects
Sponsors: Department of Veterans Affairs; Endo Pharmaceuticals Solutions Inc.; Merck
Recruiting - verified March 2010
Conditions: Premenopause; Healthy
Interventions: Drug: Estradiol steroid infusion; Drug: Progesterone steroid infusion
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified March 2010
Conditions: Breast Cancer; Cervical Cancer; Prostate Cancer; Colorectal Cancer; Lung Cancer
Interventions: Behavioral: Questionnaire; Behavioral: Patient Navigator (PN)
Sponsors: M.D. Anderson Cancer Center; Centers for Medicare and Medicaid Services
Recruiting - verified March 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin; Biological: filgrastim; Biological: graft-versus-tumor induction therapy; Biological: therapeutic allogeneic lymphocytes; Drug: busulfan; Drug: fludarabine phosphate; Drug: melphalan; Drug: methotrexate; Drug: mycophenolate mofetil; Drug: tacrolimus; Procedure: allogeneic bone marrow transplantation; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation
Sponsors: Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified June 2009
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
Interventions: Biological: alemtuzumab; Biological: therapeutic allogeneic lymphocytes; Drug: busulfan; Drug: fludarabine phosphate; Drug: tacrolimus; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation
Sponsors: UNC Lineberger Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified July 2008
Conditions: Multiple Sclerosis; Transverse Myelitis; Neuromyelitis Optica; Acute Disseminated Encephalomyelitis; Optic Neuritis
Intervention:
Sponsor: Accelerated Cure Project for Multiple Sclerosis
Recruiting - verified March 2010
Condition: Cancer
Interventions: Other: counseling intervention; Other: educational intervention; Procedure: psychosocial assessment and care
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2008
Conditions: Chronic Myeloproliferative Disorders; Secondary Myelofibrosis
Interventions: Drug: busulfan; Drug: cyclophosphamide; Drug: methotrexate; Drug: tacrolimus; Other: pharmacological study; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI)
Recruiting - verified July 2009
Condition: Essential Tremor
Intervention: Drug: Memantine
Sponsors: Forest Laboratories; Ralph M. Parsons Foundation
Recruiting - verified February 2007
Condition: Hepatitis C
Intervention:
Sponsors: Rockefeller University; New York Presbyterian Hospital
Recruiting - verified March 2010
Conditions: Morbid Obesity; Diabetes Mellitus Type 2; Insulin Resistance; Obstructive Sleep Apnea; Mood Disorders
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified July 2009
Condition: Stress
Intervention: Behavioral: Survey
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Healthy
Intervention: Behavioral: Focus Group Discussion
Sponsor: M.D. Anderson Cancer Center
Recruiting - verified March 2010
Condition: Atopic Dermatitis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Congestive Heart Failure
Intervention: Drug: Human BNP Natrecor
Sponsors: Mayo Clinic; National Institutes of Health (NIH)
Recruiting - verified February 2010
Condition: PTSD
Intervention: Drug: Paroxetine
Sponsor: Department of Veterans Affairs
Recruiting - verified March 2010
Condition: Tuberculosis
Interventions: Biological: BCG (ID); Biological: BCG (PO); Biological: Connaught strain BCG; Drug: Placebo (ID); Drug: Placebo (PO)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Conditions: Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis; Small Intestine Cancer
Interventions: Biological: therapeutic allogeneic lymphocytes; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: tacrolimus; Procedure: allogeneic hematopoietic stem cell transplantation; Procedure: in vitro-treated peripheral blood stem cell transplantation; Procedure: peripheral blood stem cell transplantation; Radiation: total-body irradiation
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2009
Conditions: Gastric Cancer; Pancreatic Cancer; Cervical Cancer; Vulvar Cancer; Endometrial Cancer; Anal Cancer
Interventions: Behavioral: Interview; Other: Questionnaire
Sponsors: M.D. Anderson Cancer Center; Merck
Recruiting - verified March 2010
Condition: Osteoarthritis
Interventions: Drug: Celecoxib; Drug: Any commercially available NSAID with the indication for osteoarthritis
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Mycobacteria, Atypical; Cystic Fibrosis; Ciliary Disorders; Pseudohypoaldosteronism; Bronchiectasis
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2010
Condition: Metabolism
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified January 2010
Condition: Fragile X Syndrome
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified February 2010
Conditions: Adolescent Mothers; Healthy; Mother-Child Relations
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified October 2009
Conditions: Kallmann's Syndrome; Hypogonadotropic Hypogonadism; Healthy Volunteers
Interventions: Drug: Letrozole; Drug: NAL-GLU GnRH antagonist; Drug: GnRH
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified March 2010
Condition: Polymorphism
Intervention:
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Recruiting - verified December 2009
Conditions: Congenital Anomalies; Imaging; Prenatal Care
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2009
Conditions: Obesity; Adipose Cell Turn Over
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
Interventions: Biological: filgrastim; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: mycophenolate mofetil; Procedure: umbilical cord blood transplantation; Radiation: total-body irradiation
Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI)
Recruiting - verified December 2009
Conditions: Breast Cancer; Fatigue; Hypothyroidism
Interventions: Other: physiologic testing; Procedure: fatigue assessment and management; Procedure: management of therapy complications
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; National Cancer Institute (NCI)
Recruiting - verified November 2009
Conditions: Healthy; Fragile X Syndrome
Intervention: Procedure: Follicle Aspiration
Sponsors: Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified March 2010
Conditions: Inflammation; Insulin Resistance
Interventions: Drug: 20% Intralipid; Drug: Salicylate
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Stem Cell Mobilization
Intervention: Drug: AMD3100
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2010
Condition: Wisdom Teeth
Intervention:
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified March 2009
Condition: Movement Disorders
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
Interventions: Biological: filgrastim; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: mycophenolate mofetil; Procedure: umbilical cord blood transplantation; Radiation: total-body irradiation
Sponsors: Masonic Cancer Center, University of Minnesota; National Cancer Institute (NCI)
Recruiting - verified October 2008
Conditions: Overweight; Obesity
Intervention: Behavioral: WOW, Working On Wellness weight management
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Narcolepsy
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2009
Condition: Ischemia
Intervention:
Sponsors: University of South Alabama; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2009
Condition: HIV Infections
Intervention: Behavioral: Community Mobilization
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting - verified February 2010
Condition: Obesity
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2009
Conditions: Aging; Mild Cognitive Impairment
Intervention: Drug: TH9507 human growth hormone releasing hormone (GHRH)
Sponsors: University of Washington; National Institute on Aging (NIA)
Recruiting - verified March 2010
Conditions: Primary Open Angle Glaucoma; Persons at Risk for Glaucoma
Intervention:
Sponsors: University of California, San Diego; National Eye Institute (NEI)
Recruiting - verified June 2008
Conditions: Metabolic Syndrome X; Insulin Resistance; Obesity; Cardiovascular Diseases
Intervention: Drug: Ortho Tri Cyclen
Sponsor: Virginia Commonwealth University
Recruiting - verified February 2010
Conditions: Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Major Depression
Interventions: Procedure: genetic analysis; Procedure: genetic assay
Sponsor: Vanderbilt University
Recruiting - verified February 2010
Condition: Multiple Myeloma
Interventions: Procedure: Stem Cell Transplant; Drug: cyclophosphamide, melphalan; Drug: Thalidomide and Dexamethasone
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified March 2010
Condition: Kinematics
Intervention: Behavioral: joint motion analysis
Sponsor: University of Florida
Recruiting - verified January 2010
Condition: Marijuana Abuse
Interventions: Drug: citicoline; Drug: placebo
Sponsors: Mclean Hospital; National Institute on Drug Abuse (NIDA)
Recruiting - verified March 2010
Condition: Adhesive Capsulitis of the Shoulder
Interventions: Procedure: Arthroscopy; Procedure: Arthroscopic manipulation; Other: Home therapy
Sponsor: University of Florida
Recruiting - verified February 2010
Conditions: Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-Hodgkin's Lymphoma; Multiple Myeloma
Interventions: Procedure: Stem Cell Transplant; Drug: Cyclophosphamide; Radiation: Total Body Irradiation; Drug: Busulfan
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified March 2010
Condition: Norovirus
Interventions: Biological: Norwalk Virus; Drug: Placebo
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Cytomegalovirus Infections
Interventions: Biological: CMV gB vaccine; Drug: Placebo; Biological: MF-59
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified November 2009
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
Interventions: Drug: busulfan; Drug: cyclophosphamide; Drug: mycophenolate mofetil; Drug: tacrolimus; Procedure: allogeneic bone marrow transplantation; Procedure: bone marrow ablation with stem cell support
Sponsors: Sidney Kimmel Comprehensive Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Healthy
Intervention: Procedure: Magnetic Resonance Spectroscopy
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified December 2009
Conditions: Attention Deficit Disorder With Hyperactivity; Mental Disorders Diagnosed in Childhood; Conduct Disorder
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified January 2010
Conditions: Hemoglobinopathies; Hemolysis; Iron Deficiency and Overload; Anemias
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 2010
Condition: Healthy
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010
Condition: Holoprosencephaly
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified October 2009
Condition: Pulmonary Fibrosis
Intervention:
Sponsor: National Human Genome Research Institute (NHGRI)
Recruiting - verified October 2009
Condition: Breast Cancer
Intervention: Drug: exemestane
Sponsor: NCIC Clinical Trials Group
Recruiting - verified March 2010
Condition: Diabetes Mellitus
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: Mood Disorders; Anxiety Disorders
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified March 2009
Conditions: Neoplasms; Hematologic Neoplasms
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2010
Condition: Neoplasms
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2009
Conditions: Diabetes Mellitus; Obesity
Intervention: Procedure: Oral glucose tolerance test
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2009
Condition: Autonomic Nervous System Diseases
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified January 2010
Condition: Anxiety Disorders
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified December 2009
Condition: Healthy
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified October 2009
Conditions: Mood Disorder; Anxiety Disorder
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
Conditions: Depression; Mood Disorder; Anxiety Disorder; Healthy
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified February 2010
Conditions: Muscle Spasticity; Healthy
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Conditions: Healthy; Sickle Cell Anemia
Intervention:
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2009
Condition: Endocrine Diseases
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified March 2009
Condition: Healthy
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified January 2010
Condition: Healthy
Intervention:
Sponsor: National Institutes of Health Clinical Center (CC)
Recruiting - verified February 2010
Conditions: Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
Conditions: Graft vs Host Disease; Healthy; Lymphopenia
Intervention: Drug: G-CSF
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2009
Condition: Hypogonadism
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified February 2010
Conditions: Cystic Fibrosis; Sarcoidosis; Tuberous Sclerosis; Asthma
Intervention:
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2010
Conditions: Coronary Disease; Obesity
Intervention:
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified January 2010
Conditions: Psychotic Disorder; Schizoaffective Disorder; Schizophrenia
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified June 2009
Condition: Pregnancy
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010
Conditions: Cardiovascular Disease; Hypertension; Non Insulin Dependent Diabetes Mellitus; Obesity
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2010
Conditions: Cryptococcosis; Lymphopenia
Intervention:
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified December 2009
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nonmalignant Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Biological: anti-thymocyte globulin; Drug: busulfan; Drug: carboplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: fludarabine phosphate; Drug: melphalan; Drug: thiotepa; Radiation: total-body irradiation
Sponsor: Roswell Park Cancer Institute
Recruiting - verified June 2009
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
